Natus neoBLUE blanket LED Phototherapy system which includes the following items: 006224 neoBL...

FDA Device Recall #Z-1412-2015 — Class II — March 16, 2015

Recall Summary

Recall Number Z-1412-2015
Classification Class II — Moderate risk
Date Initiated March 16, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Natus Medical Incorporated
Location Seattle, WA
Product Type Devices
Quantity 2611 units (1911 units in the US and 700 units outside the US)

Product Description

Natus neoBLUE blanket LED Phototherapy system which includes the following items: 006224 neoBLUE blanket LED Phototherapy Systems with Large blanket/pad 006254 neoBLUE blanket LED Light Box 006895 neoBLUE blanket LED Phototherapy Systems with Small blanket/pad 007299 neoBLUE blanket LED Phototherapy Systems with Large blanket/pad EUR 007300 neoBLUE blanket LED Phototherapy Systems with Small blanket/pad EUR 007296 neoBLUE blanket LED Phototherapy Systems with Large blanket/pad UK 007298 neoBLUE blanket LED Phototherapy Systems with Small blanket/pad UK 007301 neoBLUE blanket LED Phototherapy Systems with Large blanket/pad AUS 007302 neoBLUE blanket LED Phototherapy Systems with Small blanket/pad AUS

Reason for Recall

neoBLUE blanket LED Phototherapy System is recalled because Natus has received feedback from some customers about early failure of the neoBLUE blanket system fiberoptic pads. These failures involve discoloration and melting of the fiberoptic bundle at the connector that is inserted in the neoBLUE blanket light box.

Distribution Pattern

distributed worldwide

Lot / Code Information

None

Other Recalls from Natus Medical Incorporated

Recall # Classification Product Date
Z-0635-2024 Class II EDS 3 CSF External Drainage System, REF: NT821... Nov 28, 2023
Z-0634-2024 Class II External Drainage System Collection Bag, REF: ... Nov 28, 2023
Z-0735-2023 Class II The Natus Cranial Access Kit is designed to be ... Nov 18, 2022
Z-2701-2017 Class II The Olympic Pasteurmatic 3000 and Olympic Paste... May 22, 2017
Z-1924-2017 Class II Second generation neoBLUE LED Phototherapy Ligh... Apr 3, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.